肝细胞癌不典型表现及其模仿者:如何利用钆塞酸增强肝脏磁共振成像解决疑难病例
肝细胞癌通常可依据动脉期高强化和门脉期或延迟期廓清的无创影像特征作出诊断,但约40%的肝细胞癌表现为不典型影像特征,给放射科医生带来显著诊断挑战。本文综述肝细胞癌的典型与不典型影像特征及其常见模仿者(如肝内胆管癌、混合型肝细胞癌-胆管癌、动门脉分流和血管瘤)的影像特征,并讨论如何在实践中解决这些诊断难题。
要点
- 约40%的肝细胞癌呈不典型影像特征,需警惕并借助钆塞酸增强MRI进行鉴别。
- 肝硬化肝脏中肝内胆管癌、混合型肝细胞癌-胆管癌、动门脉分流和血管瘤可模仿肝细胞癌。
- 术前影像区分肝细胞癌与其模仿者对临床决策至关重要。
核心结论
- 约40%的肝细胞癌表现不典型影像特征,且肝硬化肝脏中多种模仿者可类似肝细胞癌,术前影像鉴别至关重要。
研究设计与样本
- 综述性文章,围绕钆塞酸增强肝脏磁共振成像,总结肝细胞癌典型与不典型影像特征及其常见模仿者的影像表现。
关键影像表现/征象
- 典型肝细胞癌表现为动脉期高强化和门脉期或延迟期廓清。
- 约40%的肝细胞癌呈不典型影像特征。
- 常见模仿者包括肝内胆管癌、混合型肝细胞癌-胆管癌、动门脉分流和血管瘤。
诊断标准与关键数值
- 肝细胞癌的无创诊断依据为动脉期高强化和门脉期或延迟期廓清。
临床应用与阅片要点
- 术前影像检查中需注意鉴别肝细胞癌与其模仿者,包括肝内胆管癌、混合型肝细胞癌-胆管癌、动门脉分流和血管瘤。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatocellular carcinoma (HCC) can be diagnosed noninvasively with contrast-enhanced dynamic computed tomography, magnetic resonance imaging, or ultrasonography on the basis of its hallmark imaging features of arterial phase hyperenhancement and washout on portal or delayed phase images. However, approximately 40% of HCCs show atypical imaging features, posing a significant diagnostic challenge for radiologists. Another challenge for radiologists in clinical practice is the presentation of many HCC mimickers such as intrahepatic cholangiocarcinoma, combined HCC-cholangiocarcinoma, arterioportal shunt, and hemangioma in the cirrhotic liver. The differentiation of HCCs from these mimickers on preoperative imaging studies is of critical importance. Hence, we will review the typical and atypical imaging features of HCCs and the imaging features of its common mimickers. In addition, we will discuss how to solve these challenges in practice.
引用
- Kim JH, Joo I, Lee JM, et al. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging. Korean J Radiol. 2019. PMID: 31270973. doi:10.3348/kjr.2018.0636
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。